RecallDepth

Medtronic, External neurostimulator, ENS (37021) & ENS (37022). Including the external neurostimulators which are associated with software application run on the NVision Clinician Programmer and used during trialing for spinal cord stimulation (SCS) patients.

This recall has been terminated (originally issued April 29, 2014).

Company
Medtronic Neuromodulation
Recall Initiated
February 27, 2014
Posted
April 29, 2014
Terminated
November 7, 2014
Recall Number
Z-1526-2014
Quantity
170,286 US, 73,921 OUS for all devices.
Firm Location
Minneapolis, MN
Official Source
View on FDA website ↗

Reason for Recall

Medtronic neurostimulators (used with pain and deep brain stimulation therapy) have a cycling feature that, when enabled, allows stimulation output to be toggled on and off based on the programmed settings. The use of this feature is determined by the physician and set using the clinician programmer. Current labeling indicates the use of cycling improves device longevity and recharge interval

Distribution

Nationwide Distribution - all states including DC and Puerto Rico.

Lot / Code Info

The first released affected product was released to the market in April, 2005.

Root Cause

Labeling False and Misleading

Action Taken

Medtronic sent a Medical Device Correction letter dated February 2014 to all affected consignees. The letter identified the product, the problem, and the action to be taken by the consignee. Consignees were instructed to do the following: If you have patients with cycling enabled or wish to use cycling, use the updated calculations and graphs available online at professional.medtronic.com/cycling to assess the impact of cycling on device longevity. Medtronic will update the product labeling in the second half of 2014. " Remind your patients to continue to check their battery status. Instructions on how to check battery status can be found in the patient programmer or recharger system manual. " Pain Stimulation Trialing Only: The cycling feature should not be enabled on the External Neurostimulator (ENS) when estimating device longevity because the resulting longevity estimate for non-rechargeable devices may not provide accurate information. Consignees were also instructed to acknowledge receipt of the notice by completing the attached reply form and returning it to Medtronic using the contact details on the reply form. For questions consignees can contact Medtronic Neuromodulation Technical services at 1-800-707-0933 weekdays 7am - 6pm CST. For questions regarding this recall call 800-707-0933.

More recalls by Medtronic Neuromodulation

View all recalls by this company →